Product Overview

Type:                           COVID-19 Vaccine (Recombinant protein subunit)

INN:                             N/A

Trade name:               Corbevax^®

EUL holder:                Biological E. Ltd.

Country:                      India

Responsible NRA:     Drug Controller General, India (DCGI)

Country:                     India

WHO EUL recommendation

Effective date:             15 January 2024

Product description

Pharmaceutical Form:                   Suspension for injection                                    

Presentation:                                   Vial

Number of doses:                           1, 10 and 20 doses (0.5 mL per dose)

Route of administration:                Intramuscular

Age indication:                                

The vaccine is indicated for individuals aged 12 years and above with at least four weeks interval between the doses. The vaccine can also be useas a booster dose ≥6 months after completion of primary immunization wiht two doses od Covishield in individials 18 years above. ​​​

Shelf – life:                                       24 months     Storage temperature:   2°C - 8°C      

Vaccine Vial monitor (VVM):        Type 14

Preservative:                                    None

Adjuvant:                                          Aluminium hydroxide and CpG1018 (as co-adjuvant) in Tris buffer.

Diluent:                                               None

Handling of opened multi-dose vials: 

WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.

Packaging description